Improved Hematologic Outcomes in HIV1-Exposed Infants Receiving Nevirapine Compared With Zidovudine for Postnatal Prophylaxis in a High Resource Setting - Université Sorbonne Paris Nord Accéder directement au contenu
Article Dans Une Revue Pediatric Infectious Disease Journal Année : 2022

Improved Hematologic Outcomes in HIV1-Exposed Infants Receiving Nevirapine Compared With Zidovudine for Postnatal Prophylaxis in a High Resource Setting

Fichier non déposé

Dates et versions

hal-03793455 , version 1 (01-10-2022)

Identifiants

Citer

Catherine Dollfus, Jérôme Le Chenadec, Laurent Mandelbrot, Roland Tubiana, Albert Faye, et al.. Improved Hematologic Outcomes in HIV1-Exposed Infants Receiving Nevirapine Compared With Zidovudine for Postnatal Prophylaxis in a High Resource Setting. Pediatric Infectious Disease Journal, 2022, 41 (5), pp.420--423. ⟨10.1097/INF.0000000000003478⟩. ⟨hal-03793455⟩
21 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More